ArticleBMJ open2024

Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3).

Phoebe Hazenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.